Developed under the principles of green chemistry, PLH is the first biocompatible, thermosetting and highly flexible copolyester on the market obtained from 100% bio- based raw materials. It is emergi...
Read moreResults showed that after a single dose, the vaccine reduced symptomatic dengue cases by around 50% with the first dose and by 62% with the second, and hospitalizations by 68%. Protection began 14 day...
Read moreOna Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...
Read moreLa acumulación de colesterol en el hígado y la mayor expresión de los genes reguladores SREBF2 y HMGCR permiten anticipar complicaciones tempranas, pérdida del injerto e incluso mortalidad, tras u...
Read moreNanoligent, a spin-off from the Institut de Recerca Sant Pau (IR Sant Pau) and the Universitat Autnoma de Barcelona (UAB), has closed a €12 million funding round led by Inveready to advance the deve...
Read moreAptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global commercialisation of ApTOLL, an aptamer with neuroprotective effect for the treatment of ischaem...
Read more300 especialistas presentan en las XV Jornadas de Bioinformática avances en la nueva ‘biología del big data’, que trae ya terapias más ajustadas a cada paciente
Read moreThe net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green
Read moreEl concejal de Promoción Económica, Pedro Martínez, ha participado hoy en la apertura del Foro de Financiación del Proyecto Iberobio que se ha celebrado en la Incubadora de Empresas Biotecnológic...
Read moreCarmen Rodríguez recibe una prestigiosa Beca INSPIRE para ser investigadora principal de un trabajo, en el que colaboran Borja Martínez, de la Universidad de Almería, y científicos de EEUU, que ex...
Read moreComplete EU pivotal trial data highlights transformative potential of aXess in hemodialysis treatment
Read moreThis spin-off of the Hospital del Mar Research Institute Barcelona seeks to make tumour cells visible by forcing them to overexpress the LCOR protein, which regulates tumour "visibility" by promoting ...
Read more